Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
!-- notag -->
Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.